Stifel Nicolaus Begins Coverage on Tempus AI (NASDAQ:TEM)

Stifel Nicolaus started coverage on shares of Tempus AI (NASDAQ:TEMFree Report) in a research report report published on Tuesday, Marketbeat Ratings reports. The firm issued a buy rating and a $45.00 price target on the stock.

Other equities analysts have also issued reports about the stock. Loop Capital assumed coverage on shares of Tempus AI in a report on Tuesday. They issued a buy rating and a $48.00 target price on the stock. TD Cowen assumed coverage on shares of Tempus AI in a report on Tuesday. They issued a buy rating and a $50.00 target price on the stock. Needham & Company LLC assumed coverage on shares of Tempus AI in a report on Tuesday. They issued a buy rating and a $47.00 price objective on the stock. Finally, JPMorgan Chase & Co. assumed coverage on shares of Tempus AI in a report on Tuesday. They issued an overweight rating and a $42.00 price objective on the stock. Nine research analysts have rated the stock with a buy rating, According to data from MarketBeat, Tempus AI has a consensus rating of Buy and an average price target of $45.63.

View Our Latest Analysis on Tempus AI

Tempus AI Stock Performance

NASDAQ:TEM opened at $39.76 on Tuesday. Tempus AI has a 1-year low of $22.89 and a 1-year high of $43.88.

About Tempus AI

(Get Free Report)

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

See Also

Analyst Recommendations for Tempus AI (NASDAQ:TEM)

Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.